High pretreatment level of soluble interleukin-2 receptor is a robust prognostic factor in patients with follicular lymphoma treated with R-CHOP-like therapy

Detalles Bibliográficos
Autores principales: Kusano, Y, Yokoyama, M, Terui, Y, Inoue, N, Takahashi, A, Yamauchi, H, Tsuyama, N, Nishimura, N, Mishima, Y, Takeuchi, K, Hatake, K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709758/
https://www.ncbi.nlm.nih.gov/pubmed/28960192
http://dx.doi.org/10.1038/bcj.2017.96
Descripción
Sumario:

Ejemplares similares